A new market intelligence report by Transparency Market Research presents a detailed overview of the global oxidative stress assay market. As per the report, titled ‘Oxidative Stress Assay Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023,’ the global market is expected to expand rapidly due to the changing trends adopted by pharmaceutical companies in research and development activities for introducing new medical devices.

Reactive oxygen species (ROS) initiate oxidative stress and could further damage various biomolecules such as lipids, proteins, DNA, and RNA. Oxidative stress is an ongoing process and causes various pathophysiological disorders and neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s, fragile X symptoms, heart and blood vessel disorders, cancer, chronic fatigue syndrome, and cardiovascular diseases. An oxidative stress assay identifies the markers of oxidative stress in cells.

Rapid growth in the pharmaceutical industry has made it possible to introduce advances in oxidative stress assays. Players such as Abcam Plc., Cell Biolabs, Inc., Oxford Biomedical Research, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., BioVision, Inc., Merck and Co., Inc., and Promega Corporation are leading the global oxidative stress assay market. Some of the major clinical laboratories operating in the global oxidative stress assay market are Alliance Imaging, Inc., Genoptix, Inc., Quest Diagnostics, and Array BioPharma Inc.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8446

The global oxidative stress assay market is segmented on the basis of end user, region, test type, product, disease type, and technology. Based on region, the global oxidative stress assay market is divided into Latin America, North America, Europe, Asia Pacific, and Rest of the World. Currently, the global oxidative stress assay market is dominated by North America, followed by Europe. The introduction of innovative technologies, the rising aging population, and the increasing public awareness have propelled the North America oxidative stress assay market in the recent past. However, Asia Pacific is predicted to register considerable growth in the near future due to rising investments in the healthcare sector.

By product, the global oxidative stress assay market is classified into instruments and consumables. The consumables segment is sub-segmented into buffers and chemicals, kits and reagents, and micro plates and antibodies. Currently, the global oxidative stress assay market is dominated by the consumables segment and is predicted to maintain its dominance in the near future. This is because of the rising use of consumables in contract research organizations (CRO) and clinical advances. The increasing use of consumables in biotechnological industries has also led to the dominance of the consumables segment.

Antioxidant capacity assays, enzyme-based assays, and reactive oxygen species (ROS)-based assays are the types of tests of oxidative stress assays. By technology, the global oxidative stress assay market is classified into ELISA, microscope, and chromatography. The introduction of new technologies and advancements in the existing ones are boosting the global market. Based on disease type, the global oxidative stress assay market is classified into cardiovascular diseases, chronic obstructive pulmonary diseases, cancer, asthma, and diabetes.

Browse Full Research Report: http://www.transparencymarketresearch.com/oxidative-stress-assay-market.html

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.